Dr. Vranjes Firenze S.p.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Dr. Vranjes Firenze S.p.A. - overview
Established
1983
Location
Florence, -, Italy
Primary Industry
Consumer Products
About
Based in Florence, Italy, and founded in 1983 by co-founders Paolo Vranjes and Anna Maria, Dr. Vranjes Firenze S. p. A.
operates as a provider of home fragrances and other interior fragrance products. In January 2024, L'Occitane International S. A. agreed to acquire a majority stake in Dr.
Vranjes Firenze S. p. A. from Bluegem Capital Partners for approximately EUR 150 million.
As of 2024, the company is led by its co-CEOs, Paolo Vranjes and Giuseppe Colotto. The company provides a wide range of luxury perfume products, such as home diffusers, decorative candles, and fragrance refills. Additionally, the firm also provides personal care items, including nourishing body creams and fragrant essences. The company generates revenue from the sale of its luxury perfume products through its e-commerce platform.
Key products include Eau de Parfum, priced at EUR 164. 00 for 100 ml; body powder, starting at EUR 65. 00; body mist, starting at EUR 59. 00; body lotion, starting at EUR 65.
00; and hair mist, starting at EUR 45. 00.
Current Investors
Bluegem Capital Partners
Primary Industry
Consumer Products
Sub Industries
Beauty & Hygiene
Website
www.drvranjes.com/
Verticals
E-commerce, Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Dr. Vranjes Firenze S.p.A. - timeline of key events
Dr. Vranjes Firenze S.p.A. - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 1,809,491 | 2,107,847 | 2,303,806 | 2,875,591 | 2,849,602 | 1,761,202 | 2,272,673 | - | - | - |
| % Revenue Growth (YoY) | - | 16.5% | 9.3% | 24.8% | (0.9%) | (38.2%) | 29.0% | - | - | - |
| EBITDA (USD) | 359,301 | 462,442 | 470,963 | 511,994 | 613,583 | 133,133 | 667,620 | - | - | - |
| Operating Income (USD) | 281,583 | 364,352 | 359,199 | 346,107 | 482,476 | (30,404) | 524,453 | - | - | - |
| Operating Margin | 15.6% | 17.3% | 15.6% | 12.0% | 16.9% | (1.7%) | 23.1% | - | - | - |
| % EBITDA Margin | 19.9% | 21.9% | 20.4% | 17.8% | 21.5% | 7.6% | 29.4% | - | - | - |
| NET Income (USD) | 175,854 | 236,051 | 248,004 | 219,440 | 344,643 | (30,418) | 421,967 | - | - | - |
| % Net Margin | 9.7% | 11.2% | 10.8% | 7.6% | 12.1% | (1.7%) | 18.6% | - | - | - |
Dr. Vranjes Firenze S.p.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Dr. Vranjes Firenze S.p.A. | - | ||||||||
| Buyout | Completed | Dr. Vranjes Firenze S.p.A. | - |
Displaying 1 - 2 of 2
Dr. Vranjes Firenze S.p.A. - employee data
Dr. Vranjes Firenze S.p.A. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| CCO – Chief Commercial Officer - Executive Board Member | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.